171 related articles for article (PubMed ID: 37099030)
101. Waldenstrom's macroglobulinaemia with amyloidosis--lymphographic findings.
Stevens DB; Whitehouse GH
Lymphology; 1976 Dec; 9(4):142-4. PubMed ID: 827660
[TBL] [Abstract][Full Text] [Related]
102. Xanthoma disseminatum and Waldenström's macroglobulinemia.
Goodenberger ME; Piette WW; Macfarlane DE; Argenyi ZB
J Am Acad Dermatol; 1990 Nov; 23(5 Pt 2):1015-8. PubMed ID: 2121806
[TBL] [Abstract][Full Text] [Related]
103. Molecular pathogenesis of Waldenstrom's macroglobulinemia.
Braggio E; Philipsborn C; Novak A; Hodge L; Ansell S; Fonseca R
Haematologica; 2012 Sep; 97(9):1281-90. PubMed ID: 22773606
[TBL] [Abstract][Full Text] [Related]
104. A Case of Diffuse and Nodular Glomerulosclerosis in Waldenstrom's Macroglobulinemia.
Lee DH; Kumar A; Radoianu N; Ehren L; Bassil C
Cureus; 2020 Sep; 12(9):e10694. PubMed ID: 33133859
[TBL] [Abstract][Full Text] [Related]
105. WALDENSTRÖM'S MACROGLOBULINEMIA MASQUERADING AS BIRDSHOT CHORIORETINOPATHY.
Kim JS; Jaworski L; Patel-Donnelly D; Nussenblatt RB; Sen HN
Retin Cases Brief Rep; 2017 Spring; 11(2):152-155. PubMed ID: 27124793
[TBL] [Abstract][Full Text] [Related]
106. Consensus Statement on the Management of Waldenström Macroglobulinemia Patients During the COVID-19 Pandemic.
Talaulikar D; Advani RH; Branagan AR; Buske C; Dimopoulos MA; D'Sa S; Kersten MJ; Leblond V; Minnema MC; Owen RG; Palomba ML; Tedeschi A; Trotman J; Varettoni M; Vos JM; Treon SP; Kastritis E; Castillo JJ
Hemasphere; 2020 Aug; 4(4):e433. PubMed ID: 32803133
[TBL] [Abstract][Full Text] [Related]
107. A 74-Year-Old Man With Waldenström Macroglobulinemia and Progressive Dyspnea.
Tzilas V; Nicholson AG; Gavriatopoulou M; Ntanasis-Stathopoulos I; Dimopoulos MA; Bouros D
Chest; 2024 Feb; 165(2):e39-e43. PubMed ID: 38336442
[TBL] [Abstract][Full Text] [Related]
108. Monoclonal gammopathy of renal significance: An atypical presentation of Waldenström's disease.
Rodríguez-Doyágüez P; Motornaya-Morozova ; Martínez-Miguel P; Castillo-Torres C; Toldos-González Ó; Gil-Fernández JJ
Clin Nephrol Case Stud; 2024; 12():17-21. PubMed ID: 38352852
[TBL] [Abstract][Full Text] [Related]
109. Amyloid consults do not have to be vexing.
D'Souza A
Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):407-412. PubMed ID: 38066929
[TBL] [Abstract][Full Text] [Related]
110. An unusual presentation of lymphoplasmacytic lymphoma with isolated brachial plexus infiltration and amyloidosis.
Giessinger J; Pullarkat ST
Blood; 2024 Mar; 143(13):1315. PubMed ID: 38546634
[No Abstract] [Full Text] [Related]
111. Case report: Waldenstrom macroglobulinemia with systemic amyloidosis as the main manifestation.
Yin J; Zhou X; Yu S; Wu H; Zhong Y
Front Med (Lausanne); 2024; 11():1340553. PubMed ID: 38707188
[TBL] [Abstract][Full Text] [Related]
112. Chinese consensus on the diagnosis and treatment of immunoglobulin light-chain cardiac amyloidosis.
Shen K; Tian Z; Gao Y; Wang Y; Huo L; Li J; Zhang Y; Zhang S;
Chin Med J (Engl); 2024 Jan; 137(2):127-129. PubMed ID: 38146261
[No Abstract] [Full Text] [Related]
113. Improving management of AL amyloidosis.
Lee YS; Huang J
Ann Acad Med Singap; 2023 Nov; 52(11):559-560. PubMed ID: 38920144
[No Abstract] [Full Text] [Related]
114. Time to Move to the Single-Cell Level: Applications of Single-Cell Multi-Omics to Hematological Malignancies and Waldenström's Macroglobulinemia-A Particularly Heterogeneous Lymphoma.
García-Sanz R; Jiménez C
Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33810569
[TBL] [Abstract][Full Text] [Related]
115. An advanced case of Waldenström's macroglobulinemia complicated by acquired hemophilia a in a patient with neurofibromatosis type 1.
Dybko Z; Jodłowski G; Borkowski A; Giordano U; Sawicki M; Dybko J
Pol Arch Intern Med; 2024 Apr; ():. PubMed ID: 38661676
[No Abstract] [Full Text] [Related]
116. Editor's Note: Eph-B2/Ephrin-B2 Interaction Plays a Major Role in the Adhesion and Proliferation of Waldenstrom's Macroglobulinemia.
Azab F; Azab AK; Maiso P; Calimeri T; Flores L; Liu Y; Quang P; Roccaro AM; Sacco A; Ngo HT; Zhang Y; Morgan BL; Carrasco RD; Ghobrial IM
Clin Cancer Res; 2024 Feb; 30(4):920. PubMed ID: 38362727
[No Abstract] [Full Text] [Related]
117. Amyloid polyneuropathy in a patient with Waldenström macroglobulinemia.
Marco DN; Aldecoa I; Sanchez-Tejerina D; Milisenda JC; Aranega R
Med Clin (Barc); 2023 Dec; 161(12):554. PubMed ID: 37661503
[No Abstract] [Full Text] [Related]
118. Report of consensus panel 2 from the 11th international workshop on Waldenström's macroglobulinemia on the management of relapsed or refractory WM patients.
D'Sa S; Matous JV; Advani R; Buske C; Castillo JJ; Gatt M; Kapoor P; Kersten MJ; Leblond V; Leiba M; Palomba ML; Paludo J; Qiu L; Sarosiek S; Shadman M; Talaulikar D; Tam CS; Tedeschi A; Thomas SK; Tohidi-Esfahani I; Trotman J; Varettoni M; Vos J; Garcia-Sanz R; San-Miguel J; Dimopoulos MA; Treon SP; Kastritis E
Semin Hematol; 2023 Mar; 60(2):80-89. PubMed ID: 37147252
[TBL] [Abstract][Full Text] [Related]
119. How I use genomics and BTK inhibitors in the treatment of Waldenström macroglobulinemia.
Treon SP; Sarosiek S; Castillo JJ
Blood; 2024 Apr; 143(17):1702-1712. PubMed ID: 38211337
[TBL] [Abstract][Full Text] [Related]
120. Current approach to Waldenström macroglobulinemia.
Kapoor P; Rajkumar SV
Blood Rev; 2023 Nov; 62():101129. PubMed ID: 37659912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
